A randomized study comparing docetaxel/cyclophosphamide followed by TC, and TC followed by FEC for p...
A randomized study comparing docetaxel/cyclophosphamide followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer
About this item
Full title
Author / Creator
Publisher
Springer
Journal title
Language
English
Formats
Publication information
Publisher
Springer
Subjects
More information
Scope and Contents
Contents
Purpose Our primary objective was to determine the benefit/risk of anthracycline-free regimens by comparing docetaxel + cyclophosphamide (TC) alone, fluorouracil + epirubicin + cyclophosphamide (FEC) followed by TC, or TC followed by FEC as a primary treatment for patients with HR-positive, HER2-negative BC. Methods We randomized patients with stag...
Alternative Titles
Full title
A randomized study comparing docetaxel/cyclophosphamide followed by TC, and TC followed by FEC for patients with hormone receptor-positive HER2-negative primary breast cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_gale_infotracmisc_A618892070
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A618892070
Other Identifiers
ISSN
0167-6806
DOI
10.1007/s10549-020-05590-w
